Levation Pharma
1 known investors
Find your way into Levation Pharma
Levation Pharma is a pharmaceutical company developing LEV-102, a topical oxymetazoline-based gel for treating acquired blepharoptosis (drooping upper eyelids). The product is in a Phase I/II clinical trial in the U.S. and is not yet approved for sale.
Investors · 1
In the news
Frequently asked questions
- What does Levation Pharma do?
- Levation Pharma is a pharmaceutical company developing LEV-102, a topical oxymetazoline-based gel for treating acquired blepharoptosis (drooping upper eyelids). The product is in a Phase I/II clinical trial in the U.S. and is not yet approved for sale.
- Who are Levation Pharma's investors?
- Levation Pharma's investors include Peregrine Ventures.